Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
M Vis, E A Havaardsholm, G Haugeberg, T Uhlig, A E Voskuyl, R J van de Stadt, B A C Dijkmans, A D Woolf, T K Kvien, W F Lems
Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1495-1499; DOI: 10.1136/ard.2005.044198
